Ayse Pinar ERCETİN, Yuksel OLGUN, Safiye AKTAS, Melek AYDİN, Hande EVİN, Zekiye ALTUN, Gunay KİRKİM, Alpin GUNERİ, Nur OLGUN

Effect of Mesenchymal Stem Cells on Cochlear Cell Viability After Cisplatin Induced Ototoxicity

Aims: Ototoxicity is one of the main side effects of the chemotherapeutic agent Cisplatin CDDP . CDDP ototoxicity is caused by damage of the organ of Corti, spiral ganglion cells or lateral wall stria vascularis and spiral ligament . Mesenchymal stem cells MSCs were shown to differentiate into neurogenic and auditory hair cells in vitro. In this study, effect of MSCs in CDDP ototoxicity model of HEI-OC1 cochlear cells was evaluated. Method: The cochlear cells were exposed to 50 and 100 microM CDDP for 24, 48, 72 hours with and without MSCs as coculture. The viability of the cells was analyzed with trypan blue dye and the percentage of apoptosis with Annexin-V by flow cytometer. The differentiation of MSCs to immature cochlear cells were shown by Math1, Calretinin and Myosin IIa immunohistochemistry. Results: At 100 microM dose, CDDP caused cytotoxicity on cochlear cells predominantly via necrosis. In co-culture, MSCs decreased cochlear cell damage of CDDP. In co-culture the ratio of Math1 and calretinin positive cells were increased supporting the idea of differentiation of MSCs into immature hair cells. Conclusion: In this in vitro study, our data support that MSCs protects cochlear cells from CDDP cytotoxicity. MSC therapy might be a candidate cellular therapy approach to overcome CDDP ototoxicity. The mechanism seems to be via differentiation of MSCs into immature hair cells. Our next step is to plan in vivo nude mice neuroblastoma animal model comparing CDDP therapy with and without systemic MSC administration and check ototoxicity.

Keywords:

mesenchymal stem cells, cochlear cells, cisplatin ototoxicity,

PDF

___

1. Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 2014;740:364–378. [CrossRef]
2. Oun R, Moussa YE, Wheate NJ. The side effects of platinumbased chemotherapy drugs: a review for chemists. Dalton Trans 2018;47:6645–6653. [CrossRef]
3. Florea AM, Büsselberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel) 2011;3:1351–1371. [CrossRef]
4. Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and prevention. Hearing Res 2007;226:157–167. [CrossRef]
5. Jayakody DMP, Friedland PL, Martins RN, Sohrabi HR. Impact of Aging on the Auditory System and Related Cognitive Functions: A Narrative Review. Front Neurosci 2018;12:125. [CrossRef]
6. Sheth S, Mukherjea D, Rybak LP, Ramkumar V. Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection. Front Cell Neurosci 2017;11:338. [CrossRef]
7. Haugnes HS, Stenklev NC, Brydøy M, et al. Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study. Acta Oncol 2018;57:1075–1083. [CrossRef]
8. Kamogashira T, Fujimoto C, Yamasoba T. Reactive oxygen species, apoptosis, and mitochondrial dysfunction in hearing loss. Biomed Res Int 2015;2015:617207. [CrossRef]
9. Im GJ, Chang JW, Choi J, Chae SW, Ko EJ, Jung HH. Protective effect of Korean red ginseng extract on cisplatin ototoxicity in HEI-OC1 auditory cells. Phytother Res 2010;24:614–21. [CrossRef]
10. Dinh CT, Chen S, Bas E, et al. Dexamethasone Protects Against Apoptotic Cell Death of Cisplatin-exposed Auditory Hair Cells In Vitro. Otol Neurotol 2015;36:1566–1571. [CrossRef]
11. Kim HS, An YS, Chang J, Choi J, Lee SH, Im GJ. Protective effect of resveratrol against cisplatininduced ototoxicity in HEI-OC1 auditory cells. Int J Pediatr Otorhinolaryngol 2014;79:58–62. [CrossRef]
12. Cho SI, Lee JE, Do NY. Protective effect of silymarin against cisplatininduced ototoxicity. Int J Pediatr Otorhinolaryngol 2014;78:474–478. [CrossRef]
13. Chang J, Jung HH, Yang JY, et al. Protective effect of metformin against cisplatin-induced ottoictyinan auditory cell line. J Assoc Res Otolaryngol 2014;15:149–158. [CrossRef]
14. Doğan S, Yazici H, Yalçinkaya E, et al. Protective Effect of Selenium Against Cisplatin-Induced Ototoxicity in an Experimental Model. J Craniofac Surg 2016;27:e610–e614. [CrossRef]
15. Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep 2015;35:e00191. [CrossRef]
16. Ouji Y, Ishizaka S, Uchiyama-Nakamura F, Wanaka A, Yoshikawa M. Induction of inner ear hair cell-like cells from Math1-transfected mouse ES cells. Cell Death and Disease 2013;4:e700. [CrossRef]
17. Yamamoto N, Okano T, Ma X, Adelstein RS, Kelley MW. Myosin II regulates extension, growth and patterning in the mammalian cochlear duct. Development 2009;136:1977–1986. [CrossRef]
18. Mahmoudian-Sani MR, Jami MS, Mahdavinez A, Amini R, Farnoosh G, Saidijam M. The Effect of the MicroRNA-183 Family on Hair CellSpecific Markers of Human Bone Marrow-Derived Mesenchymal Stem Cells. Audiol Neurotol 2018;23:208–215. [CrossRef]